-
1
-
-
0023767790
-
A new macromolecular antitumor antibiotic, C-1027, I. discovery, taxonomy of producing organism fermentation and biological activity [J]
-
Hu JL, Xue YC, Xie MY, et al. A new macromolecular antitumor antibiotic, C-1027, I. discovery, taxonomy of producing organism fermentation and biological activity [J]. J Antibiot (Tokyo), 1988,41:1575-1579.
-
(1988)
J Antibiot (Tokyo)
, vol.41
, pp. 1575-1579
-
-
Hu, J.L.1
Xue, Y.C.2
Xie, M.Y.3
-
2
-
-
0024315075
-
A new macromolecular antitumor antibiotic. C-1027, HI. antitumor activity [J]
-
Zhen YS, Ming XY, Yu B, et al. A new macromolecular antitumor antibiotic. C-1027, HI. antitumor activity [J]. J Antibiot (Tokyo), 1989,42:1294-1298.
-
(1989)
J Antibiot (Tokyo)
, vol.42
, pp. 1294-1298
-
-
Zhen, Y.S.1
Ming, X.Y.2
Yu, B.3
-
3
-
-
0025679319
-
Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma Bel-7402 cells [J]
-
Xu YJ, Li DD, Zhen YS. Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma Bel-7402 cells [J]. Cancer Chemother Pharmacol, 1990,27:41-46.
-
(1990)
Cancer Chemother Pharmacol
, vol.27
, pp. 41-46
-
-
Xu, Y.J.1
Li, D.D.2
Zhen, Y.S.3
-
4
-
-
0028901279
-
Induction of apoptosis by enediyne antitumor antibiotic C-1027 in HL-60 human promylocytic leukemia cells [J]
-
Jiang B, Li DD, Zhen YS. Induction of apoptosis by enediyne antitumor antibiotic C-1027 in HL-60 human promylocytic leukemia cells [J]. Biochem Biophys Res Commun, 1995,208:238-244.
-
(1995)
Biochem Biophys Res Commun
, vol.208
, pp. 238-244
-
-
Jiang, B.1
Li, D.D.2
Zhen, Y.S.3
-
5
-
-
0025354772
-
Mechanism of action of a new macromolecular antitumor antibiotic, C-1027 [J]
-
Sugimito Y, Otani T, Oier S, et al. Mechanism of action of a new macromolecular antitumor antibiotic, C-1027 [J]. J. Antibiotic (Tokyo), 1990,43:417-421.
-
(1990)
J. Antibiotic (Tokyo)
, vol.43
, pp. 417-421
-
-
Sugimito, Y.1
Otani, T.2
Oier, S.3
-
6
-
-
34548014314
-
Down-regulation of the nuclear factor-kappa B by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth [J]
-
Chen J, Ouyang ZG, Zhang SH, et al. Down-regulation of the nuclear factor-kappa B by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth [J]. Oncol Rep, 2007, 17:1445-1451.
-
(2007)
Oncol Rep
, vol.17
, pp. 1445-1451
-
-
Chen, J.1
Ouyang, Z.G.2
Zhang, S.H.3
-
7
-
-
33847230885
-
Chemosensitivity of mdr1 gene overexpressed multidrug resistant cancer cells to lidamycin [J]
-
Shi YK, Wu SY, Huang YH, et al. Chemosensitivity of mdr1 gene overexpressed multidrug resistant cancer cells to lidamycin [J]. Acta Pharm Sin, 2006, 41:1146-1151.
-
(2006)
Acta Pharm Sin
, vol.41
, pp. 1146-1151
-
-
Shi, Y.K.1
Wu, S.Y.2
Huang, Y.H.3
-
8
-
-
0031219006
-
Inhibition of angiogenesis by antitumor antibiotic C1027 and its effect on tumor metastasis [J]
-
Zhen HY, Xue YC, Zhen YS. Inhibition of angiogenesis by antitumor antibiotic C1027 and its effect on tumor metastasis [J]. Natl Med J China, 1997,77:657-660.
-
(1997)
Natl Med J China
, vol.77
, pp. 657-660
-
-
Zhen, H.Y.1
Xue, Y.C.2
Zhen, Y.S.3
-
9
-
-
36349007731
-
Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface [J]
-
Kawakubo T, Okamoto K, Iwata J, et al. Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface [J]. Cancer Res, 2007,67:10869-10878.
-
(2007)
Cancer Res
, vol.67
, pp. 10869-10878
-
-
Kawakubo, T.1
Okamoto, K.2
Iwata, J.3
-
10
-
-
34247107995
-
Effect of lidamycin on mitochondria initiated apoptotic pathway in human cancer cells [J]
-
Qiu Q, Wang Z, Jiang JM, et al. Effect of lidamycin on mitochondria initiated apoptotic pathway in human cancer cells [J]. Acta Pharm Sin, 2007,42: 132-138.
-
(2007)
Acta Pharm Sin
, vol.42
, pp. 132-138
-
-
Qiu, Q.1
Wang, Z.2
Jiang, J.M.3
-
11
-
-
20044375603
-
Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro [J]
-
Wang Y, Fei D, Vanderlaan M. Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro [J]. Angiogenesis, 2004,7:335-345.
-
(2004)
Angiogenesis
, vol.7
, pp. 335-345
-
-
Wang, Y.1
Fei, D.2
Vanderlaan, M.3
|